Cargando…
Targeting primary acute myeloid leukemia with a new CXCR4 antagonist IgG1 antibody (PF-06747143)
The chemokine receptor CXCR4 mediates cell anchorage in the bone marrow (BM) microenvironment and is overexpressed in 25–30% of patients with acute myeloid leukemia (AML). Here we have shown that a new CXCR4 receptor antagonist IgG1 antibody (PF-06747143) binds strongly to AML cell lines and to AML...
Autores principales: | Zhang, Yanyan, Saavedra, Erika, Tang, Ruoping, Gu, Yin, Lappin, Patrick, Trajkovic, Dusko, Liu, Shu-Hui, Smeal, Tod, Fantin, Valeria, De Botton, Stephane, Legrand, Ollivier, Delhommeau, Francois, Pernasetti, Flavia, Louache, Fawzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544749/ https://www.ncbi.nlm.nih.gov/pubmed/28779088 http://dx.doi.org/10.1038/s41598-017-07848-8 |
Ejemplares similares
-
Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia
por: Kashyap, Manoj K., et al.
Publicado: (2017) -
Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia
por: Hirsch, Pierre, et al.
Publicado: (2016) -
CXCL12/CXCR4 pathway is activated by oncogenic JAK2 in a PI3K-dependent manner
por: Abdelouahab, Hadjer, et al.
Publicado: (2016) -
CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model
por: Zhang, Y, et al.
Publicado: (2012) -
Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells
por: Bouchet, Sandrine, et al.
Publicado: (2014)